Results 61 to 70 of about 5,787 (193)

Olanzapine / fluoxetine combination for treatment resistant depression : efficacy and clinical utility

open access: yes, 2008
Antidepressant monotherapy is a first-line treatment for depression; however, not all sufferers will adequately respond to treatment. When treating a patient with treatment-resistant depression, the clinician needs to consider all factors which may ...
Beasley   +47 more
core   +1 more source

Class effect of pharmacotherapy in bipolar disorder: fact or misbelief? [PDF]

open access: yes, 2011
BACKGROUND: Anecdotal reports suggests that most clinicians treat medications as belonging to a class with regard to all therapeutic indications; this means that the whole 'class' of drugs is considered to possesses a specific therapeutic action.
Eduard Vieta   +3 more
core   +3 more sources

COMORBIDITY OF DEPRESSIVE AND DERMATOLOGIC DISORDERS – THERAPEUTIC ASPECTS [PDF]

open access: yes, 2009
Depressive disorders are more common in the population affected with dermatologic disorders. Comorbidity of depression and dermatologic disorders is around 30%. The correlation between depressive and dermatologic disorders still remains unclear.
Anamarija Petek   +4 more
core   +1 more source

Acute and repeated treatment with the 5-HT_7 receptor antagonist SB 269970 induces functional desensitization of 5-HT_7 receptors in rat hippocampus [PDF]

open access: yes, 2012
Bobula, Bartosz   +8 more
core   +1 more source

Antidepressants in Inflammatory Bowel Disease: : A systematic review [PDF]

open access: yes, 2017
Macer, Benjamin   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy